简介内容:WM382, a potent orally active dual plasmepsin IX/X (PMIX/X) inhibitor, demonstrates significant efficacy across multiple stages of the malaria parasite life cycle with IC50 values of nM and nM, respectively. It also exhibits an excellent resistance profile.